Saturday 17 October 2026 Export TARS’s income statement to Excel — free account

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $451.4 million, up 146.7% from fiscal 2024. In the quarter to June 2026, revenue grew 69.4%, EPS grew 10.4%, free cash flow grew 288.1% and total debt was flat, each against the same quarter a year earlier.

68.07 2.92 −4.11%

Follow TARS

Alert me

Market cap: $3.5B
P/E: 0.0×
Fwd P/E: −92.6×
Dividend yield: —
F-score: 5/9
Altman Z: 9.54
Beneish M: −1.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	5	5	5	5	+8 more TTM periods Free account
ROE Full definition →	(13.68%)	(13.96%)	(23.39%)	(28.35%)
ROA Full definition →	(8.40%)	(8.92%)	(14.14%)	(17.82%)
ROIC Full definition →	0.00%	(96.77%)	0.00%	(988.67%)
Return on Tangible Assets Full definition →	(11.43%)	(11.73%)	(16.66%)	(20.79%)
Average Days of Receivables Full definition →	59.18	79.95	70.44	74.11
Free Cash Flow per Share Full definition →	1.29	(0.73)	(0.53)	(1.35)
Free Cash Flow Full definition →	56.00	(31.54)	(22.31)	(57.54)
Capital Expenditures Full definition →	(18.15)	(15.09)	(9.86)	(3.57)
Other line items
Cash ROIC Full definition →	6.44%	(3.89%)	(2.68%)	(7.11%)
Accounts Receivable Turnover Full definition →	7.65	5.90	6.68	7.00
Accounts Payable Turnover Full definition →	0.69	0.69	2.38	0.31
Inventory Turnover Full definition →	9.88	9.58	8.78	7.39
Average Days of Payables Full definition →	359.59	252.60	194.93	1,530.48
Days of Inventory on Hand Full definition →	39.21	47.86	52.01	56.72
Tax Rate Full definition →	0.13	0.05	0.00	0.00
Research and Development Expense of Revenue Full definition →	14.46%	13.51%	14.25%	17.25%
Selling, General and Administrative Expense of Revenue Full definition →	86.82%	89.47%	94.67%	99.88%
Share Based Compensation of Revenue Full definition →	8.55%	8.74%	9.24%	9.51%
Interest Coverage Full definition →	(5.54)	(5.74)	(7.94)	(9.68)
Operating CF/Net income Full definition →	(1.60)	0.34	0.19	0.66
Depreciation/Fixed assets Full definition →	(0.05)	(0.15)	(0.26)	(0.64)
Capex/Depreciation Full definition →	16.55	5.78	3.21	0.98
Revenue per Share Full definition →	13.97	12.46	10.80	8.59
Operating CF per Share Full definition →	1.71	(0.38)	(0.30)	(1.27)
Capex per Share Full definition →	(0.42)	(0.35)	(0.24)	(0.08)
Capex to Sales Full definition →	0.03	0.03	0.02	0.01

Show all line items

Columns are period end dates

Stockrow Weekly